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AbsTrACT
Objective Diagnosing coronary artery disease (caD) 
continues to require substantial healthcare resources. 
acoustic analysis of transcutaneous heart sounds of 
cardiac movement and intracoronary turbulence due to 
obstructive coronary disease could potentially change 
this. the aim of this study was thus to test the diagnostic 
accuracy of a new portable acoustic device for detection 
of caD.
Methods We included 1675 patients consecutively 
with low to intermediate likelihood of caD who had 
been referred for cardiac ct angiography. if significant 
obstruction was suspected in any coronary segment, 
patients were referred to invasive angiography and 
fractional flow reserve (FFr) assessment. heart sound 
analysis was performed in all patients. a predefined 
acoustic caD-score algorithm was evaluated; 
subsequently, we developed and validated an updated 
caD-score algorithm that included both acoustic features 
and clinical risk factors. low risk is indicated by a caD-
score value ≤20.
results haemodynamically significant caD assessed 
from FFr was present in 145 (10.0%) patients. in the 
entire cohort, the predefined caD-score had a sensitivity 
of 63% and a specificity of 44%. in total, 50% had an 
updated caD-score value ≤20. at this cut-off, sensitivity 
was 81% (95% ci 73% to 87%), specificity 53% (95% 
ci 50% to 56%), positive predictive value 16% (95% 
ci 13% to 18%) and negative predictive value 96% 
(95% ci 95% to 98%) for diagnosing haemodynamically 
significant caD.
Conclusion sound-based detection of caD enables 
risk stratification superior to clinical risk scores. With 
a negative predictive value of 96%, this new acoustic 
rule-out system could potentially supplement clinical 
assessment to guide decisions on the need for further 
diagnostic investigation.
Trial registration number  clinicaltrials. gov identifier 
nct02264717; results.
InTrOduCTIOn
Diagnosing patients with symptoms suggestive of 
obstructive coronary artery disease (CAD) continues 
to require substantial healthcare resources. Despite 
several attempts to improve clinical pretest risk scoring 
algorithms for obstructive CAD, the incidence of a 
normal diagnostic test remains high.1 2 A continued 
high rate of inappropriate Invasive coronary 
angiography (ICA) in de novo patients has been crit-
icised in particular because it is costly and carries the 
risk of complications. Hence, there is a pertinent need 
for more accurate risk stratification tools providing 
high negative predictive value (NPV) to accurately 
rule out obstructive CAD to avoid further diagnostic 
testing.3 
One plausible way to obtain this goal may be to 
use advanced analysis of sounds originating from 
blood flow turbulence in the coronary circulation 
during diastole. Acoustic detection of obstructive 
CAD is non-invasive, radiation free and economically 
favourable. This makes the technique attractive for 
primary risk stratification. Recent advances in sound 
sensor technology, analytic power and data filtering 
have enabled the use of acoustic detection to diagnose 
intracoronary turbulence due to obstructive CAD. In 
addition to weak murmurs related to intracoronary 
turbulence recent approaches have analysed further 
aspects of the heart sounds which might relate to 
myocardial compliance and resonance frequencies 
of the coronary artery tree.4–7 Several methodolog-
ical studies describe the frequency range and timing 
of turbulence associated with obstructive CAD, and 
several companies have developed European Confor-
mity marked equipment with different algorithms 
to diagnose obstructive CAD.8 These developments 
have paved the way for investigation of the tech-
nique in clinical practice.5 8 9 Hence, small-scale pilot 
studies of different acoustic devices have demon-
strated NPVs in the range 71%–98% suggesting that 
they may be used as rule-out modalities.4 10 11
In the present study of acoustic detection of CAD, 
we aimed to test an acoustic device in a low to inter-
mediate risk population using both quantitative 
coronary angiography (QCA) and invasive fractional 
flow reserve (FFR) as references. Two algorithms 
were tested: a previously used acoustic algorithm, 
CAD-score Version 2 (V2) (per protocol), which was 
developed using patients included in pilot studies; and 
a new algorithm, CAD-score V3, by combining an 
updated acoustic algorithm and clinical risk factors.
MATerIAls And MeThOds
study design and population
The present study is a predefined substudy of the 
Danish study of Non-Invasive testing in Coronary 
Artery Disease (Dan-NICAD). Patients referred to 
cardiac CT angiography (CTA) as first-line test due 
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to a history of symptoms suggestive of obstructive CAD were 
consecutively enrolled. Referral decision was taken during an 
outpatient visit by a cardiologist based on echocardiography, 
patient history and risk profiling according to national and Euro-
pean Society of Cardiology guidelines.12 Exclusion criteria were: 
(1) age <40; (2) previous coronary revascularisation; (3) esti-
mated glomerular filtration <40 mL/min; (4) pregnancy; and (5) 
contraindication for iodine-containing contrast medium, MRI 
or adenosine (severe asthma, advanced atrioventricular block 
or critical aorta stenosis). All patients signed a written informed 
consent form. 
All patients underwent a systematic interview to assess risk 
factors and symptoms to calculate the updated Diamond-For-
rester score (DF score).13 In connection with the cardiac CTA, 
examination was performed with the acoustic CADScor®System 
(Acarix A/S, Denmark). Patients with suspicion of a coronary 
stenosis at cardiac CTA underwent ICA with FFR. Patients 
without stenosis at cardiac CTA were terminated from the study 
(figure 1). The study design, imaging protocols and analysis 
strategy have been published.14
CAd-score
Heart sound recordings were obtained transcutaneously with 
the CADScor®System (Acarix A/S) microphone mounted at 
the fourth intercostal space just to the left of the sternum using 
a dedicated adhesive patch. The patient lied down for 3 min 
during the recording and was asked to hold his/her breath four 
times, each time for 8 s (figure 2). As the equipment may be 
influenced by excessive noise, the tests were conducted in an 
undisturbed room. The CAD-score was estimated immediately 
after the recording with a fully automated and device embedded 
algorithm.4 5 9 15 If the recording quality was insufficient the 
recording device requested a new recording. In these cases, a 
second attempt was made to calculate the CAD-score. The algo-
rithm combines four measures (Features) of acoustic properties 
from the diastolic heart sounds which relate to murmurs and 
other heart sound characteristics into a score (figure 2 and online 
supplementary material).
An updated score, using the CAD-score V3 algorithm, was 
calculated using postprocessing of the audio recordings obtained 
with the recording device. The updated algorithm measures 
eight acoustic properties and the resulting acoustic score was 
combined with the clinical risk factors gender, age and hyper-
tension, defined as systolic blood pressure ≥140 mm Hg or 
receiving antihypertension medicine (figure 2 and online supple-
mentary material). The updated CAD-score V3 algorithm was 
developed using a heart sound database (Acarix A/S) with record-
ings from patients included in previous pilot studies, published 
data, and a training cohort of the first 593 consecutively enrolled 
patients from the present Dan-NICAD study.4 The remaining 
Figure 1 Flow chart of patients in the study for final diagnosis of CAD. *A CAD-score Version 2 was not calculated in 190 patients and CAD-score 
Version 3 was not calculated in 204 patients. Median intertest interval from the cardiac CTA to the ICA was 30 days (10th and 90th percentiles: 14 
and 50 days). CACS, coronary artery calcium score; CAD, coronary artery disease; CAG, invasive coronary angiography; CTA, CT angiography; FFR, 
fractional flow reserve; ICA, invasive coronary angiograph; QCA, quantitative coronary angiography.
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1082 patients in the Dan-NICAD study were used as a validation 
cohort and remained blinded to the developer of the CAD-score 
V3 algorithm.
Coronary CTA
All cardiac CTA scans were performed using a 320-slice volume 
CT scanner (Aquilion One, Toshiba Medical Systems, Japan) 
according to clinical guidelines. CT imaging analysis included 
an Agatston calcium score and evaluation of luminal diameter 
stenosis estimation in each segment of the coronary tree using 
an 18-segment model. Coronary lesions were evaluated blinded 
to the invasive angiographic findings by an experienced cardi-
ologist. Stenosis severity was classified in all segments with a 
reference vessel diameter >2 mm as no stenosis: 0% diameter 
reduction; mild stenosis: 1%–29% diameter reduction; moderate 
stenosis: 30%–49% diameter reduction; and severe stenosis: 
50%–100% diameter reduction. Segments with suspected severe 
stenosis and non-evaluable segments with a reference vessel diam-
eter >2 mm were defined as having obstructive CAD by cardiac 
CTA. The cardiac CTA was defined as abnormal if obstruc-
tive CAD was not ruled out in all coronary segments. CAD 
severity was further categorised based on the coronary artery 
calcium score (CACS) and coronary stenosis severity; non-CAD: 
CACS=0 and no plaque; mild CAD: CACS≥0 and plaque with 
maximal mild stenosis; moderate CAD: CACS≥0 and plaque 
with moderate stenosis; and severe CAD: CACS≥0 and plaque 
with severe stenosis.
Invasive coronary angiography
The ICA examination was performed according to clinical guide-
lines. Intracoronary nitroglycerine was administered before the 
first angiographic acquisition.
QCA analysis was done using QAngioXA V.7.3 software in 
an independent core lab (ClinFact, Leiden, The Netherlands). 
Anatomically significant obstructive CAD was defined as a 
coronary artery with a luminal diameter reduction ≥50% in a 
segment with a reference vessel diameter >2 mm.
Invasive FFR was measured in lesions with a visualised, 
estimated 30%–90% diameter stenosis located in vessels with 
a reference diameter >2.0 mm using a clinical FFR system 
(Aeris, St. Jude Medical, USA). Haemodynamically significant 
obstructive CAD was identified in a blinded core lab as: (1) FFR 
value <0.80, (2) luminal diameter stenosis reduction >90%, 
or (3) luminal diameter stenosis reduction ≥50% if FFR was 
indicated but not performed for technical, anatomical or other 
reasons.
statistical analysis
Variables are expressed as mean (±SD or total range) or median 
(range) according to the Gaussian distribution. Categorical vari-
ables are reported as frequencies (percentages). The unpaired 
Student’s t-test and analysis of variance test were used for 
comparison between Gaussian-distributed variables. Wilcoxon 
rank-sum test and the χ2 test were used for comparison between 
non-Gaussian distributed and categorical variables, respectively. 
Pearson’s test and Spearman’s test were used to analyse correla-
tions of variables of Gaussian and non-Gaussian distributions, 
respectively. The area under the receiver operating character-
istic curve was calculated for continuous variables and compared 
with the method described by DeLong et al.16 The CAD-score 
was divided as a binary variable with a cut point of >20; and 
sensitivity, specificity, positive predictive value, NPV, and posi-
tive and negative likelihood ratios were calculated.
For development of CAD-score V3, the cohort was split in 
training and validation cohorts according to a prespecified date. 
Diagnostic accuracy of CAD-score V3 for the training and vali-
dation cohort is presented in online supplementary table S2 
Figure 2 Depiction of the CAD-score acquisition and the two 
CAD-score algorithms. The heart sounds were recorded at the fourth 
intercostal space with patients in a supine position. The preprocessing 
part of the algorithm organised the heart sounds for analysis through 
segmentation and filtering. After preprocessing, the acoustic features 
were extracted from the sounds and an acoustic score was constructed 
using LDA. In CAD-score Version 3 (V3), the acoustic score was 
further combined with gender, age and hypertension using logistic 
regression. AMI, automutal information; FPR, frequency power ratio; 
HRV, heart rate variability; LDA, linear discriminant analysis; PCARand, 
principle component analyses-based measure of the randomness; 
PCASpec, principle component analysis of the diastolic frequency 
spectrum; S2freq, frequency distribution of the second heart sounds; 
S4amp, amplitude of the fourth heart sound; SampEn, sample entropy; 
SpecSlope, slope of diastolic frequency spectrum; SysFPR, systolic 
frequency power ratio.
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and pooled together in the Results section due to similar diag-
nostic performance in the two cohorts. Statistical analyses were 
performed using STATA V.13.1 (StataCorp, USA).
resulTs
A total of 1675 patients were included. Eleven patients (0.7%) 
were excluded because they did not complete either the CACS 
or the cardiac CTA. The acoustic CAD-score V2 could not 
be obtained in 190 patients (11.3%), and CAD-score V3 was 
missing in another 14 patients (online supplementary table S1). 
Of these, four patients (0.2%) had missing cardiac CTA data 
(figure 1).
Baseline and cardiac CTA characteristics are summarised in 
table 1. Of the patients referred for ICA, 325 patients (91.8%) 
completed the investigation. Of these, 153 (47.1%) were classi-
fied with obstructive CAD by core lab QCA, while 145 patients 
(44.6%) had haemodynamically obstructive disease based on ICA 
and FFR (figure 1, table 1). In total, the prevalence of anatomi-
cally significant obstructive CAD was 10.6%, and the prevalence 
of haemodynamically significant obstructive CAD was 10.0%. 
No adverse events related to the acoustic system were recorded.
CAd-score V2
The diagnostic accuracy of acoustic CAD-score V2 for diag-
nosing anatomically obstructive stenosis evaluated by area under 
the curve (AUC) was 58.1% (95% CI 53.6% to 62.6%), which 
was significantly lower than the DF score, 65.9% (95% CI 
61.2% to 70.4%) (P<0.01). Diagnostic accuracy parameters 
with both anatomically and haemodynamically obstructive 
stenosis as references are listed in table 2. There were no differ-
ences in diagnostic accuracy with the use of anatomically versus 
haemodynamically obstructive stenosis as a reference.
CAd-score V3
The acoustic part of the CAD-score V3 was higher for men than 
for women, 25.2±10.4 vs 19.3±9.7 (P<0.001). Only a weak 
correlation was demonstrated with age (r=0.11, P<0.001), 
body mass index (r=−0.19, P<0.001), systolic blood pressure 
(r=0.10, P<0.001), diastolic blood pressure (r=0.02, P=0.50) 
and CACS (r=0.17, P<0.001). In the presence of a coronary 
stenosis at ICA, a weak correlation with max QCA percentage 
diameter stenosis was observed (r=0.14, P<0.05). Patients 
with anatomically obstructive stenosis had a significantly higher 
acoustic CAD-score V3 than patients without, 24.4±10.2 vs 
21.9±10.4 (P<0.01). The AUC for diagnosing anatomically 
obstructive stenosis of the acoustic part of the CAD-score V3 
was 63.3% (95% CI 58.7% to 67.8%). This was significantly 
higher than the previous acoustic CAD-score V2 (P<0.05), and 
similar to that of the DF score (P=0.40).
The final CAD-score V3, which includes both an acoustic part 
and risk factors, correlated moderately with CACS (r=0.38, 
P<0.001). The CAD-score V3 was associated with CAD severity 
when stratified by (1) CACS groups (P<0.001), (2) CAD disease 
severity defined by cardiac CTA (P<0.001) and (3) obstructive 
disease (P<0.001) identified by cardiac CTA (figure 3).
The mean CAD-score V3 was higher for patients with 
haemodynamically significant CAD than for patients without, 
29.9±12.0 vs 20.4±12.0 (P<0.001). In patients with a stenosis 
on ICA, CAD-score V3 correlated with maximal QCA diameter 
stenosis (r=0.23, P<0.001) and increased with QCA diameter 
stenosis severity (P<0.01) (online supplementary figure S1). 
However, no such correlation was present for FFR measure-
ments in patients with 30%–90% diameter stenosis on visual 
Table 1 Patient demographics and imaging study characteristics
Characteristic (n=1474)
Race, Caucasian 1464 (99.3%)
Sex, male 719 (48.8%)
Age (years) 57.2±8.8
Genetic predisposition* 557 (37.8%)
Body mass index (kg/m²) 26.7±4.1
Abdominal circumference (cm) 93.0±12.6
Blood pressure
  Systolic 138±19
  Diastolic 83±11
Heart rate† 65±11
Smoking
  Never 703 (47.7%)
  Former 538 (36.5%)
  Active 233 (15.8%)
Diabetes 79 (5.4%)
symptoms (n=1474)
Typical chest pain 410 (27.8%)
Atypical chest pain 495 (33.6%)
Non-specific 569 (38.6%)
CCS Functional Classification of Angina ≥2
  1 (angina only with strenuous exertion) 1054 (71.5%)
  ≥2 (angina with moderate or severe exertion) 113 (7.7%)
Updated Diamond-Forrester score 39% (20%–54%)
Risk groups according to updated Diamond-Forrester score
  Low risk (<15%) 210 (14.2%)
  Moderate risk (≥15% and 85%) 1229 (83.4%)
  High risk (≥85%) 35 (2.4%)
echo (n=1474)
Left ventricular ejection fraction 59.9%±3.4
Cardiac valve disease, any 71 (4.8%)
  Aorta insufficiency (mild to moderate) 36 (2.4%)
  Other systolic valve disease (mild to moderate) 35 (2.4%)
Coronary artery calcium score (CACs) (n=1474)
Median 0 (0–80)
Coronary artery calcium score groups
  None (=0) 753 (51.1%)
  Low/moderate (1–399) 567 (38.5%)
  High (≥400) 154 (10.4%)
Cardiac CT angiography‡ (n=1470)
Coronary artery disease severity
  Non (stenosis 0% and CACS=0) 702 (47.8%)
  Mild (stenosis 0%–29%) 306 (20.8%)
  Moderate (stenosis 30%–49%) 112 (7.6%)
  Severe (stenosis 50%–100%) 350 (23.8%)
Invasive coronary angiography (QCA, anatomic disease)‡ (n=325)
Coronary artery disease severity
  Mild stenosis (0%–29%) 74 (5.1%)
  Moderate stenosis (30%–49%) 98 (6.8%)
  Severe stenosis (50%–100%, anatomically obstructive 
stenosis)
153 (10.6%)
Vessel disease
  Left main coronary artery 7 (0.05%)
  Left anterior descending coronary artery 96 (6.6%)
  Left circumflex coronary artery 53 (3.7%)
  Right coronary artery 67 (4.6%)
Coronary vessel disease
  One-vessel disease 94 (6.5%)
Continued
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estimate (r=0.01, P=0.98). There was a statistically significant 
stepwise increase in CAD-score V3 with increasing number of 
diseased vessels. There was no relation between CAD-score V3 
and the anatomical location of the stenosis (table 3).
The diagnostic accuracy for the training (n=593) versus the 
validation (n=1082) cohort is summarised in online supplemen-
tary table S2.
Table 2 features the CAD-score V3 diagnostic accuracy with 
both anatomically and haemodynamically obstructive stenosis 
as references. The CAD-score V3 for diagnosing anatomically 
obstructive stenosis had an AUC of 72.4% (95% CI 68.0% to 
76.8%). This was significantly higher than the AUC of both 
the DF score 65.9% (P<0.01) and the CAD-score V2 58.1% 
(P<0.001), and the acoustic part of the CAD-score V3 63.3% 
(P<0.001) when analysed in the full cohort. The AUCs of these 
algorithms for haemodynamically obstructive stenosis with 
FFR as a reference are illustrated in figure 4. Frequency plot, 
2×2 table, and sensitivity and specificity curves with haemo-
dynamically obstructive stenosis as reference are illustrated in 
figure 5. In total, 27 patients had false-negative CAD-scores and 
of these, 48.1% were men, mean age was 52.7 years, mean body 
mass index was 27.1, and mean left ventricular ejection fraction 
was 60.4%. 
dIsCussIOn
In this large, first-of-its-kind prospective trial, we evaluated a 
novel acoustic technique for primary risk stratification and 
rule-out of obstructive CAD. We studied a cohort of symptom-
atic patients with low to intermediate risk of CAD referred to 
cardiac CTA. This patient cohort represents a relevant clinical 
setting where the use of an accurate rule-out device could have 
clinical impact. All patients in the trial had either a cardiac CTA 
or an ICA to rule out coronary stenosis. Furthermore, suspected 
stenosis at ICA was verified with both core lab QCA and invasive 
FFR.
CAd-score V2
The isolated acoustic CAD-score V2 had a significantly lower 
diagnostic accuracy for predicting coronary stenosis than a DF 
score which is recommended in clinical guidelines. However, 
both the CAD-score V2 and the DF score performed poorly in 
this low-risk cohort of patients referred to cardiac CTA (prev-
alence of CAD=10%) compared with a previous study with a 
moderate/high-risk cohort consisting of patients referred to 
either cardiac CTA or ICA (prevalence of CAD=28%).4 Hence, 
present versus previously published AUCs with anatomically 
obstructive stenosis as reference were: CAD-score V2: 58% 
vs 72%; and DF score: 65% vs 79%. The CAD-score V2 was 
developed using 228 primarily moderate/high-risk patients and 
previously only validated by cross validation. These facts might 
have induced an overfit of the algorithm to cohorts with a higher 
CAD prevalence.
CAd-score V3
Data from the updated CAD-score V3 are presented from both 
the training and the validation cohorts owing to similar accu-
racy between the two cohorts. A moderate association between 
CAD-score V3 and CACS was detected in this study; we demon-
strated a significant difference in the mean CAD-score between 
the CACS groups. The acoustic risk score as determined by either 
  Two-vessel disease 42 (2.9%)
  Three-vessel disease or LM disease 17 (1.2%)
Invasive coronary angiography (FFr, haemodynamic disease)‡ (n=325)
Coronary artery disease severity
  Non-severe stenosis (FFR>0.8 or diameter stenosis<30%) 180 (12.4%)
  Severe stenosis (FFR<0.8), haemodynamically obstructive 
stenosis
145 (10.0%)
Vessel disease
  Left main coronary artery 7 (0.05%)
  Left anterior descending coronary artery 117 (8.1%)
  Left circumflex coronary artery 41 (2.8%)
  Right coronary artery 55 (3.8%)
Coronary vessel disease
  One-vessel disease 88 (6.1%)
  Two-vessel disease 39 (2.7%)
  Three-vessel disease or left main coronary artery disease 18 (1.2%)
Values are n (%) or mean±SD or median (IQR).
*Coronary artery disease among first-degree relatives aged less than 60 years.
†Mean heart rate at the time of CAD-score measurement was 54±7 bpm and at the 
time of CTA was 56±7 bpm.
‡Cardiac CTA data were missing in four patients and ICA data were missing in 25 
patients with an indication to ICA due to severe CAD at cardiac CTA.
CAD, coronary artery disease; CCS, Canadian Cardiovascular Society; 
CTA, CT angiography; FFR, fractional flow reserve; ICA, Invasive coronary 
angiography;  QCA, quantitative coronary angiography.
Table 1 Continued Table 2 Diagnostic accuracy of CAD-score with a cut-off of >20 
according to a reference of (A) anatomically obstructive stenosis 
diagnosed with core lab QCA and (B) haemodynamically obstructive 
stenosis diagnosed with invasive FFR as reference
CAd-score Version 2 CAd-score Version 3
A. Anatomically obstructive stenosis
Number of patients 1450 1437
  True positive 100 119
  False positive 720 606
  True negative 577 683
  False negative 53 29
Accuracy analysis
  Sensitivity 65.4 (95% CI 57.3 to 72.9) 80.4 (95% CI 73.1 to 86.5)
  Specificity 44.5 (95% CI 41.8 to 47.2) 53.0 (95% CI 50.2 to 55.7)
  PPV 12.2 (95% CI 10.0 to 14.6) 16.4 (95% CI 13.8 to 19.3)
  NPV 91.6 (95% CI 89.1 to 93.6) 95.9 (95% CI 94.2 to 97.3)
  PLR 1.18 (95% CI 1.04 to 1.33) 1.71 (95% CI 1.56 to 1.88)
  NLR 0.78 (95% CI 0.62 to 0.98) 0.37 (95% CI 0.27 to 0.51)
  AUC 58.1 (95% CI 53.6 to 62.6) 72.4 (95% CI 68.0 to 76.8)
b. haemodynamically obstructive stenosis
Number of patients 1450 1437
  True positive 92 113
  False positive 728 612
  True negative 577 685
  False negative 53 27
Accuracy analysis
  Sensitivity 63.4 (95% CI 55.1 to 71.3) 80.7 (95% CI 73.2 to 86.9)
  Specificity 44.2 (95% CI 41.5 to 47.0) 52.8 (95% CI 50.0 to 55.6)
  PPV 11.2 (95% CI 9.1 to 13.6) 15.6 (95% CI 13.0 to 18.4)
  NPV 91.6 (95% CI 89.1 to 93.6) 96.2 (95% CI 94.5 to 97.5)
  PLR 1.14 (95% CI 1.00 to 1.30) 1.71 (95% CI 1.56 to 1.89)
  NLR 0.83 (95% CI 0.66 to 1.03) 0.36 (95% CI 0.25 to 0.50)
  AUC 56.8 (95% CI 51.8 to 61.7) 71.3 (95% CI 66.8 to 75.8)
AUC, area under the curve; FFR, fractional flow reserve; NLR, negative likelihood 
ratio; NPV, negative predictive value; PLR, positive likelihood ratio; PPV, positive 
predictive value; QCA, quantitative coronary angiography.
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the CADScor®System device or the Cardiac Sonospectrographic 
Analyzer (CSA, SonoMedica, Vienna, Virginia) has previously 
shown weak correlation with CACS.4 10 Hence, the inclusion 
of risk factors (gender, age and hypertension) to the algorithm 
increased the correlation with CACS, which previously demon-
strated high prognostic value.17 18
Comparable accuracy was detected when using QCA and 
FFR as reference standard of disease despite the fact that the 
CAD-score was optimised in order to detect stenosis accessed 
by QCA. Compared with the DF score, the CAD-score V3 was 
more accurate in detecting anatomically obstructive CAD, and a 
trend was seen towards a high accuracy for haemodynamically 
obstructive CAD. In addition, CAD-score V3 increased with the 
number of affected coronary vessels by cardiac CTA and ICA. 
Importantly, CAD-score V3 was not related to the location of 
the stenosis.
Acoustic recording and diagnostic algorithm
Several acoustic methods are currently being tested for detection 
of coronary stenosis.8 The recording system used in this study is 
mounted by a single-use adhesive patch at the fourth intercostal 
space, and recordings are performed automatically during four 
short breath holds over a 3 min recording period. The result is 
subsequently calculated and presented on the device display. Other 
systems use multiple record positions, handheld and elastic strap 
Figure 3 CAD-score Version 3 divided by: (A) coronary artery calcium 
score groups; (B) CAD disease severity defined by cardiac CTA; (C) 
haemodynamically obstructive coronary vessel disease by cardiac CTA. 
Box plot illustrated median, IQR and adjacent values.  CACS, coronary 
artery calcium score; CAD, coronary artery disease; CTA, CT angiography; 
LM, left main.
Table 3 Relation between haemodynamically obstructive disease 
distribution at ICA and mean CAD-score Version 3 (n=320)
All patients
CAd-score 
Version 3 P value
  No disease 26.3±12.0 <0.05
  One-vessel disease 28.7±11.7
  Two-vessel disease 31.6±11.5
  Three-vessel or left main coronary artery disease 32.5±13.9
  Left main coronary artery 32.8±16.4 0.97
  Left anterior descending coronary artery 30.6±12.0
  Left circumflex coronary artery 31.8±11.4
  Right coronary artery 30.3±12.3
Patients with one-vessel disease*
  Left main coronary artery NA 0.50
  Left anterior descending coronary artery 29.4±11.6
  Left circumflex coronary artery 24.6±6.8
  Right coronary artery 26.7±12.5
*The number of patients with haemodynamically obstructive one-vessel disease at 
ICA was 84 in total: left anterior descending coronary artery (n=63), left circumflex 
coronary artery (n=4) and right coronary artery (n=17).
NA, not applicable.
Figure 4 The area under the receiver operating characteristic curve 
for Diamond-Forrester score, acoustic CAD-score Versions 2 and 3, 
and CAD-score Version 3 with haemodynamically obstructive stenosis 
diagnosed as reference.
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attachment, and one system performs records simultaneously with 
an electrocardiographic signal. The methodological differences 
have inherent limitations and advantages. The adhesive patches 
may reduce microphone noise and inter-recording variability. 
Single versus multiple recording positions may limit the ability to 
differentiate between stenosis locations. Individual body composi-
tions may be crucial for correct placement of the recording devices 
and sound quality. Similarly, there are major differences in software 
algorithms and which spectral frequency ranges are included.8 
These differences need to be highlighted to further optimise both 
the equipment and the algorithm. Finally, studies of how patient 
characteristics, coronary plaque length, location, compositions and 
flow impact the acoustic patterns are lacking and insights from 
such studies could potentially enhance system performance.
The latest UK NICE (National Institute for Health and Care 
Excellence) guideline update CG95: Chest pain of recent onset, 
includes the acoustic device as a clinically relevant prediction 
model with an AUC ranging from 72% to 82%, alone or in combi-
nation with the DF score.
Comparing the sensitivity of this acoustic device with the 
sensitivity of other large-scale, presently used techniques is also 
relevant; for example, exercise ECG (sensitivity 45%–50%), 
exercise stress echocardiography (sensitivity 80%–85%) and 
exercise stress SPECT (73%–92%).12 Thus, the above-men-
tioned techniques have false negative rates above or similar to 
those reported in the present study. Nonetheless, these other 
diagnostic modalities have previously all been proven to hold 
substantial prognostic value, which still needs to be demon-
strated for acoustic rule-out algorithms.
The health economic impact of acoustic rule-out of patients with 
symptoms suggestive of obstructive CAD could be substantial. As 
mentioned above, the acoustic system seems to perform similarly 
to other established techniques in ruling out CAD, but its use 
comes at a potentially much lower cost.
limitations
The cohort was almost exclusively Caucasian (99%), and with 
a documented low to intermediate prevalence of CAD. Thus, 
Key messages
What is already known on this subject?
 Recent advances in sound sensor technology, analytic power 
and data filtering have enabled the use of acoustic detection to 
diagnose intracoronary turbulence due to obstructive coronary 
artery disease (CAD).
What might this study add? 
In this large, first-of-its-kind prospective trial, we demonstrated 
that acoustic detection of CAD enables risk stratification in 
patients with suspected CAD.
how might this impact on clinical practice?
The negative predictive value of this device suggests that it may 
be used as a rule-out modality, which is highly relevant in daily 
clinical practice.
Figure 5 Plots of CAD-score Version 3 accuracy of haemodynamically obstructive coronary stenosis diagnosed with fractional flow reserve (FFR) as 
reference. Illustrated are a frequency plot, 2×2 table according to a binary CAD-score cut-off >20, and sensitivity and specificity curves with 95% CI 
bands shown. 
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generalisation to other populations with other ethnic backgrounds, 
higher prevalence and other healthcare environments may not be 
possible. Higher CAD-scores were observed for a low number of 
patients with heart valve disease, however only when adding the 
clinical risk factors, indicating that patients with heart valve disease 
are diagnosed accurately. Finally, the development of CAD-score 
V3 required splitting of the cohort into a training and a validation 
cohort, which could have overfitted the results in the total cohort 
analysis.
COnClusIOn
The sound-based recording device, the CADScorSystem, enables 
risk stratification in patients with suspected CAD. With an NPV of 
96%, this new acoustic rule-out system could potentially supple-
ment clinical assessment to guide decisions on the need for further 
investigation and thereby reduce the demand for more advanced 
and costly diagnostic modalities.
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